A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineRecruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials